Ambrx Home PageAbout AmbrxPipeline &TechnologyStrategic AlliancesNewsCareers







Media Contact

For media inquiries, please contact:

Heidi Chokeir or David Schull
Russo Partners, LLC
Tel: +1 (619) 528-2217
email: heidi.chokeir@russopartnersllc.com
david.schull@russopartnersllc.com

news

Press Releases

[+] September 22, 2003
Ambrx Assembles World Class Team and Raises $12.5 Million to Apply Breakthrough

SAN DIEGO, CA – September 22, 2003 – Ambrx, Inc., a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics, announced that Richard D. DiMarchi, Ph.D. has been appointed as founding Chief Executive Officer and Thomas O. Daniel, M.D. has joined the company as Chief Scientific Officer.… Read More

Articles

 
© Copyright 2005-2010 Ambrx, Inc.   All rights reserved.